Chemistry

At LAXAI Life Sciences, we excel in leveraging comprehensive medicinal chemistry and synthetic chemistry approaches to drive drug discovery services forward. Our team comprises experienced scientists trained at leading institutions worldwide, ensuring the highest quality and innovation in every small molecule R&D project. We offer flexible project-specific teams led by dedicated principal scientists, providing innovative solutions to accelerate the programs of our customers within a robust CRDMO services framework. From library synthesis to preclinical Tox-batch, LAXAI Life Sciences delivers excellence in medicinal chemistry services and synthetic chemistry services.

Medicinal Chemistry

We focus on precise target validation and innovative hit identification, expediting the drug discovery process. Utilizing advanced bioinformatics and structural analysis, we ensure the strength and reliability of target molecules before embarking on hit identification, strengthening our position in integrated drug discovery.

Synthetic Chemistry

With over 15 years of domain expertise, we’ve been instrumental in advancing platform technologies for delivering exploratory and intricate chemistries, employing both parallel and conventional methods. Our specialized kilo laboratory and cutting-edge analytical infrastructure facilitate rapid compound production for pharmaceutical research and development. Backed by a team of over 400 skilled scientists, we offer innovative, cost-efficient, and environmentally friendly solutions aligned with CRDMO services.

Our Services

ADCs (Antibody-Drug Conjugates)

We specialize in developing powerful cytotoxic payloads and stable linker chemistries, alongside site-specific conjugation techniques for precise delivery to cancer cells. Our diverse expertise guarantees minimal off-target effects and enhances patient outcomes within advanced drug discovery services.

PROTAC (Proteolysis Targeting Chimera)

At the forefront of targeted protein degradation technology, we specialize in designing and synthesizing bifunctional molecules for precise protein modulation. Our innovations are revolutionizing therapeutic approaches for cancer and neurodegenerative diseases, reinforcing leadership in small molecule drug discovery.

Nucleosides and Nucleotides

We excel in synthesizing modified nucleosides and nucleotides essential for antiviral drugs, RNA therapeutics, and gene editing tools. Our expertise extends to optimizing synthetic pathways to yield high-quality building blocks.

Peptides

We specialize in designing, synthesizing, and modifying peptides for therapeutic use. Our expertise includes employing conjugation strategies to improve stability, enhance bioavailability, and enable targeted delivery within drug development solutions.

Carbohydrates

We specialize in synthesizing complex carbohydrates and glycoconjugates with unique properties tailored for specific targeting and modulation of immune responses in drug discovery programs.

Lipids

Well-versed in synthesizing and characterizing lipids essential for mRNA vaccine delivery and gene therapy, supporting advanced biopharmaceutical research.

Carbocyclic Chemistry

Pioneered in synthesizing complex heterocyclic molecules for pharmaceutical applications, with expertise in constructing carbocyclic frameworks to enhance efficacy across small molecule R&D.

Asymmetric Synthesis

Specialist in chiral synthesis using advanced organometallic techniques, strengthening capabilities in synthetic chemistry services.

Scaffolds & Building Blocks Synthesis

Design and synthesis of complex molecular scaffolds and building blocks. Facilitation of novel routes for rapid library construction, supporting scalable drug discovery services.